MITRA.BR WACC - Weighted Average Cost of Capital
The WACC of Mithra Pharmaceuticals SA (MITRA.BR) is 5.6%.
| Range | Selected | |
| Cost of equity | 7.6% - 19.0% | 13.3% |
| Tax rate | 12.2% - 16.1% | 14.15% |
| Cost of debt | 4.8% - 7.0% | 5.9% |
| WACC | 4.5% - 6.7% | 5.6% |
| Category | Low | High |
| Long-term bond rate | 2.9% | 3.4% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.8 | 2.17 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.6% | 19.0% |
| Tax rate | 12.2% | 16.1% |
| Debt/Equity ratio | 15.81 | 15.81 |
| Cost of debt | 4.8% | 7.0% |
| After-tax WACC | 4.5% | 6.7% |
| Selected WACC | 5.6% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| MITRA.BR | Mithra Pharmaceuticals SA | 15.81 | 0.76 | 0.05 |
| AMYT.L | Amryt Pharma Holdings Ltd | 0.34 | 0.05 | 0.04 |
| CALTX.ST | Calliditas Therapeutics AB | 0.08 | -0.02 | -0.02 |
| CAMX.ST | Camurus AB | 0 | 0.39 | 0.39 |
| CLN.WA | Celon Pharma SA | 0.01 | 0.42 | 0.41 |
| COPN.SW | Cosmo Pharmaceuticals NV | 0 | 0.88 | 0.87 |
| INDEX.ST | InDex Pharmaceuticals Holding AB | 0.01 | -0.92 | -0.91 |
| MARI.VI | Marinomed Biotech AG | 0.83 | 0.13 | 0.07 |
| SECARE.ST | Swedencare AB (publ) | 0.24 | 0.44 | 0.37 |
| SHE.MI | Shedir Pharma Srl Unipersonale | 0.15 | -0.16 | -0.14 |
| Low | High | |
| Unlevered beta | 0.05 | 0.19 |
| Relevered beta | 0.7 | 2.75 |
| Adjusted relevered beta | 0.8 | 2.17 |
MITRA.BR's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for MITRA.BR:
cost_of_equity (13.30%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (0.8) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.